Live Geos (CANADIAN TRAFFIC ONLY): https://partners.subjectwell.com/publishers/geos_report/0b1eea88-84e3-45a6-98ad-349c70f92efa Ages: 18+ Gender: All *ALL COPY AND CREATIVE OUTSIDE OF WHAT IS PROVIDED MUST BE SENT TO [email protected] BEFORE GOING LIVE* Study Description: The purpose of this clinical study is to test if the use of a commercialized asthma medication can preserve long term lung function in people with moderate to severe asthma. If you are eligible, you will be asked to attend a screening visit to determine if you can enroll in the study. If enrolled, you will receive either study medication or placebo to be given as an injection once every 2 weeks for 3 years. You will have a 2:1 chance of being assigned to study medication versus the placebo. The study medication will be given alongside current standard of care asthma therapy. Your total participation will last approximately 3 years and 4 months and you will be asked to attend 15 doctor’s visits. During these visits, you will complete various diagnostic and laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated for time and travel. Your information may be transferred to jurisdictions located outside your province or country of residence to determine your eligibility for the study. - Cannot also be diagnosed with: - Cystic fibrosis, Pulmonary fibrosis, Chronic obstructive pulmonary disease (COPD), or Emphysema - Cannot receive dialysis treatments for chronic kidney failure - Cannot be current smoker Study ID: 5911b182-7375-404f-ab46-3329ea700ddf

ProfitsNXT